preliminary trials
More News
-
China optimises treatment for COVID-19
Tocilizumab, with the common brand name Actemra, has been included in China's latest version of diagnosis
Tocilizumab, with the common brand name Actemra, has been included in China's latest version of diagnosis
This material may not be published, broadcast, rewritten, redistributed or derived from. Unless otherwise stated, all content is copyrighted © 2025 The Express Tribune.